Skip to main content
. 2022 Apr 5;65(11):1883–1894. doi: 10.1007/s00125-022-05685-7

Table 1.

Monitoring in diabetes and considerations for precision monitoring

Monitoring method Monitored variable Mode of monitoring Considerations for precision monitoring
Laboratory analysis

HbA1c

Glucose

Lipids

Markers of inflammation

Genetic information

Active Monitoring of risk-factors for complications
Self-monitored blood glucose

Current glucose level

Distribution of glucose values

Active

Dose adaptation

Definition of risk groups for acute complications

Frequency of required measurements is uncertain

Blinded CGM

Retrospective daily glucose control

Distribution of glucose values

Passive

Definition of risk groups for acute complications

Glucose patterns

Meeting of treatment targets

No reactive measurement of glycaemic control

Possibility of intermittent use is uncertain

Real-time CGM

Past glucose course

Current glucose level

Trend in glucose level

Distribution of glucose values

Passive/active

Definition of risk groups for acute complications

Glucose patterns

Meeting of treatment targets

Possibility of intermittent use is uncertain

EMA

Mental health (patient-reported outcomes):

Stress

Mood/Affect

Diabetes distress

Quality of life

Depressive symptoms

Diabetes symptoms

Fear of hypoglycaemia

Active

Identification of impaired mental health

Automated analysis resulting in meaningful variables needed

Automated integration with glucose data needed

Timing and duration of prompts is uncertain

Number of daily prompts is uncertain

Use of validated questions from established questionnaires is uncertain

Self-care behaviour (self-report), eating:

Meal size

Timing

Food choices

Portion size

Context of eating (e.g. stress eating, boredom)

Disordered eating

Active

Effect of lifestyle interventions

Motivation for lifestyle interventions

Visibility of the effects of different foods on glucose

Potential bias by socially desirable responses

Self-care behaviour (self-report), treatment adherence:

Timing of medication (e.g. insulin)

No. of medications taken/injections

Dosage of medication

Active

Effect of monitoring on adherence

Potential bias by socially desirable responses

Self-care behaviour (self-report), sleep:

Sleep-in and wake-up time

Sleep quality

Active

Impact of sleep quality on glucose metabolism (vice versa)

Mental health and sleep

Potential bias by socially desirable responses

Wearable sensor-wristbands

Physical activity:

Steps

Distance covered

Heart rate

Intensity

Oxygen saturation

Passive

Effect of lifestyle interventions

Motivation for lifestyle interventions

Visibility of the effects of physical activity on glucose

Correspondence to self-report

Validity of data is difficult to ascertain

Additional device(s) to wear

Sleep:

Sleeping hours

Time in non-REM/REM

Number of awakenings

Breathing

Passive

Identification of sleep problems

Objective variables in addition to perceived sleep quality

Validity of data is difficult to ascertain

Additional device(s) to wear

Physiological arousal:

Heart rate

Heart rate variability

Heart rhythm

Passive

Objective variables of stress responsiveness

Validity of data is difficult to ascertain

Additional device(s) to wear

Smart pens, pump data storage, electronic medication caps

Treatment adherence:

Timing of medication (e.g. insulin)

No. of medications taken/injections

Dosage of medication

Passive

Detailed analysis of diabetes management

Correspondence to self-report

Costs

Availability